Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter

References

• Soler-Cataluña JJ, Rodriguez-Roisin R. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious? COPD. 2010;7(4):276–284. doi:10.3109/15412555.2010.496817
   PubMedGoogle Scholar
• Wedzicha JA, Rabe KF, Martinez FJ, et al. Efficacy of roflumilast in the COPD frequent exacerbator phenotype. Chest. 2013;143(5):1302–1311. doi:10.1378/chest.12-1489
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Seemungal TAR. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Izquierdo JL, Juárez Campo M, Sicras-Mainar A, Nuevo J. Impact of COPD exacerbations and burden of disease in Spain: AVOIDEX study. Int J Chron Obstruct Pulmon Dis. 2023;18:1103–1114. doi:10.2147/COPD.S406007
   PubMed Web of Science ®Google Scholar
• Deniz S, Şengül A, Aydemir Y, Çeldir Emre J, Özhan MH. Clinical factors and comorbidities affecting the cost of hospital-treated COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:3023–3030. doi:10.2147/COPD.S120637
   PubMed Web of Science ®Google Scholar
• Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995;274(23):1852–1857. doi:10.1001/jama.1995.03530230038027
   PubMed Web of Science ®Google Scholar
• Han MK, Bartholmai B, Liu LX, et al. Clinical significance of radiologic characterizations in COPD. COPD. 2009;6(6):459–467. doi:10.3109/15412550903341513
   PubMedGoogle Scholar
• Oh Y-M, Sheen S-S, Park JH, et al. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD. Int J Tuberc Lung Dis. 2014;18(12):1407–1414. doi:10.5588/ijtld.14.0205
   PubMed Web of Science ®Google Scholar
• Lim JU, Kim EK, Lim SY, et al. Mixed phenotype of emphysema and airway wall thickening is associated with frequent exacerbation in chronic obstructive pulmonary disease patients. Int J Chron Obstruct Pulmon Dis. 2019;14:3035–3042. doi:10.2147/COPD.S227377
   PubMed Web of Science ®Google Scholar
• Maselli DJ, Yen A, Wang W, et al. Small airway disease and emphysema are associated with future exacerbations in smokers with CT-derived bronchiectasis and COPD: results from the COPDGene cohort. Radiology. 2021;300(3):706–714. doi:10.1148/radiol.2021204052
   PubMed Web of Science ®Google Scholar
• Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261(1):274–282. doi:10.1148/radiol.11110173
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Bafadhel M, Umar I, Gupta S, et al. The role of CT scanning in multidimensional phenotyping of COPD. Chest. 2011;140(3):634–642. doi:10.1378/chest.10-3007
   PubMed Web of Science ®Google Scholar
• Wilgus ML, Abtin F, Markovic D, et al. Panlobular emphysema is associated with COPD disease severity: a study of emphysema subtype by computed tomography. Respir Med. 2022;192:106717. doi:10.1016/j.rmed.2021.106717
   PubMed Web of Science ®Google Scholar
• Kim WJ, Silverman EK, Hoffman E, et al. CT metrics of airway disease and emphysema in severe COPD. Chest. 2009;136(2):396–404. doi:10.1378/chest.08-2858
   PubMed Web of Science ®Google Scholar
• Perera WR, Hurst JR, Wilkinson TMA, et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007;29(3):527–534. doi:10.1183/09031936.00092506
   PubMed Web of Science ®Google Scholar
• Gompertz S, O’Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J. 2001;17(6):1112–1119. doi:10.1183/09031936.01.99114901
   PubMed Web of Science ®Google Scholar
• Crooks SW, Bayley DL, Hill SL, Stockley RA. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J. 2000;15(2):274–280. doi:10.1034/j.1399-3003.2000.15b09.x
   PubMed Web of Science ®Google Scholar
• Chen -T-T, S-M W, Chen K-Y, et al. Suppressor of variegation 3–9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD. BMC Pulm Med. 2021;21(1):276. doi:10.1186/s12890-021-01628-x
   PubMed Web of Science ®Google Scholar
• Bhowmik A, Seemungal TA, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000;55(2):114–120. doi:10.1136/thorax.55.2.114
   PubMed Web of Science ®Google Scholar
• J-J F, McDonald VM, Baines KJ, Gibson PG. Airway IL-1β and systemic inflammation as predictors of future exacerbation risk in asthma and COPD. Chest. 2015;148(3):618–629. doi:10.1378/chest.14-2337
   PubMed Web of Science ®Google Scholar
• Zhao D, Abbasi A, Rossiter HB, et al. Serum amyloid A in stable COPD patients is associated with the frequent exacerbator phenotype. Int J Chron Obstruct Pulmon Dis. 2020;15:2379–2388. doi:10.2147/COPD.S266844
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Zheng J, Zhong N. Normative values of pulmonary function testing in Chinese adults. Chin Med J. 2002;115(1):50–54.
   PubMed Web of Science ®Google Scholar
• Jairam PM, van der Graaf Y, Lammers J-WJ, Willem PT, de Jong PA. Incidental findings on chest CT imaging are associated with increased COPD exacerbations and mortality. Thorax. 2015;70(8):725–731. doi:10.1136/thoraxjnl-2014-206160
   PubMed Web of Science ®Google Scholar
• Ostridge K, Williams NP, Kim V, et al. Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res. 2018;19(1):31. doi:10.1186/s12931-018-0734-y
   PubMedGoogle Scholar
• Donaldson GC, Wedzicha JA. COPD exacerbations.1: epidemiology. Thorax. 2006;61(2):164–168. doi:10.1136/thx.2005.041806
   PubMed Web of Science ®Google Scholar
• Charbonnier J-P, Pompe E, Moore C, et al. Airway wall thickening on CT: relation to smoking status and severity of COPD. Respir Med. 2019;146:36–41. doi:10.1016/j.rmed.2018.11.014
   PubMed Web of Science ®Google Scholar
• Dunican EM, Elicker BM, Henry T, et al. Mucus plugs and emphysema in the pathophysiology of airflow obstruction and hypoxemia in smokers. Am J Respir Crit Care Med. 2021;203(8):957–968. doi:10.1164/rccm.202006-2248OC
   PubMed Web of Science ®Google Scholar
• Kim V, Davey A, Comellas AP, et al. Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res. 2014;15(1):52. doi:10.1186/1465-9921-15-52
   PubMedGoogle Scholar
• Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med. 2010;181(4):353–359. doi:10.1164/rccm.200907-1008OC
   PubMed Web of Science ®Google Scholar
• Uddin M, Watz H, Malmgren A, Pedersen F. NETopathic inflammation in chronic obstructive pulmonary disease and severe asthma. Front Immunol. 2019;10:47. doi:10.3389/fimmu.2019.00047
   PubMed Web of Science ®Google Scholar
• Day K, Ostridge K, Conway J, et al. Interrelationships among small airways dysfunction, neutrophilic inflammation, and exacerbation frequency in COPD. Chest. 2021;159(4):1391–1399. doi:10.1016/j.chest.2020.11.018
   PubMed Web of Science ®Google Scholar
• Benjamin JT, Plosa EJ, Sucre JM, et al. Neutrophilic inflammation during lung development disrupts elastin assembly and predisposes adult mice to COPD. J Clin Invest. 2021;131(1). doi:10.1172/JCI139481
   Web of Science ®Google Scholar
• Mochimaru T, Chubachi S, Irie H, et al. Blood eosinophil and neutrophil counts differentially identify frequent exacerbation in patients with COPD with physician-diagnosed asthma and COPD. Allergol Int. 2021;70(2):255–257. doi:10.1016/j.alit.2020.09.004
   PubMed Web of Science ®Google Scholar
• Khan YM, Kirkham P, Barnes PJ, Adcock IM, Taube C. Brd4 is essential for IL-1β-induced inflammation in human airway epithelial cells. PLoS One. 2014;9(4):e95051. doi:10.1371/journal.pone.0095051
   PubMed Web of Science ®Google Scholar
• Pauwels NS, Bracke KR, Dupont LL, et al. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J. 2011;38(5):1019–1028. doi:10.1183/09031936.00158110
   PubMed Web of Science ®Google Scholar
• Wei B, Sheng Li C. Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease. J Int Med Res. 2018;46(9):3890–3902. doi:10.1177/0300060518781642
   PubMed Web of Science ®Google Scholar
• Broekhuizen R, Wouters EFM, Creutzberg EC, Schols AMWJ. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax. 2006;61(1):17–22. doi:10.1136/thx.2005.041996
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370(9589):797–799. doi:10.1016/S0140-6736(07)61383-X
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008
   PubMed Web of Science ®Google Scholar
• Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010;65(10):930–936. doi:10.1136/thx.2009.130260
   PubMed Web of Science ®Google Scholar
• J-j F, Baines KJ, Wood LG, Gibson PG. Systemic inflammation is associated with differential gene expression and airway neutrophilia in asthma. OMICS. 2013;17(4):187–199. doi:10.1089/omi.2012.0104
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu J, Meng Y, Adcock IM, Yao X. Role of inflammatory cells in airway remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:3341–3348. doi:10.2147/COPD.S176122
   PubMed Web of Science ®Google Scholar
• Adibi A, Sin DD, Safari A, et al. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study. Lancet Respir Med. 2020;8(10):1013–1021. doi:10.1016/S2213-2600(19)30397-2
   PubMed Web of Science ®Google Scholar
• Kreuter M, Cottin V. The threat in chronic lung diseases: acute exacerbations. Eur Respir Rev. 2017;26(145):170075. doi:10.1183/16000617.0075-2017
   PubMed Web of Science ®Google Scholar